Publications

Pilot clinical trial of neoadjuvant toll-like receptor 7 agonist (Imiquimod) immunotherapy in early-stage oral squamous cell carcinoma

Download PDF
Resource: Pilot clinical trial of neoadjuvant toll-like receptor 7 agonist (Imiquimod) immunotherapy in early-stage oral squamous cell carcinoma

.

Related Articles

A novel murine syngeneic CD8 peripheral T-cell lymphoma model with preclinical applications

Link
Intracellular complement Factor H promotes tumor progression through modulation of cell cycle and actin cytoskeleton

Link